MA43834A - Combinaison pour traiter la douleur - Google Patents

Combinaison pour traiter la douleur

Info

Publication number
MA43834A
MA43834A MA043834A MA43834A MA43834A MA 43834 A MA43834 A MA 43834A MA 043834 A MA043834 A MA 043834A MA 43834 A MA43834 A MA 43834A MA 43834 A MA43834 A MA 43834A
Authority
MA
Morocco
Prior art keywords
combination
treat pain
pain
treat
Prior art date
Application number
MA043834A
Other languages
English (en)
Inventor
Eyup Akgun
Daniel John Bruce
Carolyn Ann Fairbanks
Philip S Portoghese
George Latimer Wilcox
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of MA43834A publication Critical patent/MA43834A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA043834A 2016-03-22 2017-03-22 Combinaison pour traiter la douleur MA43834A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662311781P 2016-03-22 2016-03-22

Publications (1)

Publication Number Publication Date
MA43834A true MA43834A (fr) 2018-11-28

Family

ID=59900848

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043834A MA43834A (fr) 2016-03-22 2017-03-22 Combinaison pour traiter la douleur

Country Status (7)

Country Link
US (1) US11529340B2 (fr)
EP (1) EP3432884A4 (fr)
JP (1) JP2019509321A (fr)
AU (1) AU2017238208B2 (fr)
CA (1) CA3018750A1 (fr)
MA (1) MA43834A (fr)
WO (1) WO2017165558A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3873447A1 (fr) * 2018-10-29 2021-09-08 Hadasit Medical Research Services and Development Ltd. Combinaison de modulateurs du récepteur m-opioïde (mor) à des fins de prévention et de traitement de la douleur, de la suicidalité et de troubles mentaux

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4816586A (en) 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
ES2121988T3 (es) 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
KR100341950B1 (ko) 1993-07-19 2002-11-29 도레이 가부시끼가이샤 뇌세포보호제
AU686203B2 (en) 1993-07-23 1998-02-05 Toray Industries, Inc. Morphinan derivative and medicinal use
SE9401727D0 (sv) 1994-05-18 1994-05-18 Astra Ab New compounds I
US6609682B2 (en) 2001-07-19 2003-08-26 Burl A. Rogers Airplane landing gear suspension and shock-absorbing device
US7202259B2 (en) 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US7687080B2 (en) * 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
CA2720312A1 (fr) 2004-01-30 2005-08-18 Euro-Celtique S.A. Procedes d'elaboration de composes de 4-tetrazolyl-4-phenylpiperidine
JP5266492B2 (ja) 2004-05-28 2013-08-21 ヒューマン バイオモレキュラル リサーチ インスティテュート 代謝安定性鎮痛薬、疼痛薬物療法及び他の物質の合成
CA2593165A1 (fr) * 2005-01-05 2006-07-13 Regents Of The University Of Minnesota Conjugues analgesiques
EP1888568A4 (fr) * 2005-05-18 2009-08-12 Neuraxon Inc Composes de benzimidazole substitues a action a la fois inhibitrice de nos et agoniste opioide mu
WO2007035823A2 (fr) 2005-09-20 2007-03-29 Molecular Neuroimaging, Llc Antagonistes partiels de mglur5 et leurs méthodes d'utilisation
US8461171B2 (en) 2010-02-09 2013-06-11 QRxPharma Ltd. Hybrid opioid compounds and compositions
US10130674B2 (en) 2010-02-09 2018-11-20 Creative Bio-Peptides Modified peptide that reduces pain in peripheral neuropathy
WO2014124317A1 (fr) 2013-02-08 2014-08-14 Regents Of The University Of Minnesota Conjugués analgésiques
US10464941B2 (en) 2015-02-24 2019-11-05 Regents Of The University Of Minnesota Therapeutic compounds

Also Published As

Publication number Publication date
AU2017238208B2 (en) 2022-01-06
WO2017165558A1 (fr) 2017-09-28
US11529340B2 (en) 2022-12-20
JP2019509321A (ja) 2019-04-04
AU2017238208A1 (en) 2018-11-01
US20200289489A1 (en) 2020-09-17
CA3018750A1 (fr) 2017-09-28
EP3432884A4 (fr) 2019-11-20
EP3432884A1 (fr) 2019-01-30

Similar Documents

Publication Publication Date Title
IL271085A (en) Bacteria for the treatment of disorders
EP3463464A4 (fr) Traitement d'association
IL263680A (en) Combination therapies
PL3265053T3 (pl) Sposoby leczenia skóry
EP3466435C0 (fr) Agent améliorant la fonction cérébrale
EP2968010A4 (fr) Stimulation auditive-somatosensorielle personnalisée pour traiter un acouphène
HUE061761T2 (hu) Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében
DK3811943T3 (da) Forbindelse til anvendelse til behandling af øjenlidelser
SI3518783T1 (sl) Naprava za zmanjševanje tkiva
EP3245009C0 (fr) Applicateur antiseptique
EP3564335A4 (fr) Agent de traitement de surface
EP3500242A4 (fr) Forme posologique fibreuse
IL256206A (en) Mct4 inhibitors for treating disease
EP3378606A4 (fr) Combinaison d'assistance
SI4119569T1 (sl) Konjugirane protismiselne spojine za uporabo v terapiji
PL3236960T3 (pl) Fluralaner do zastosowania w leczeniu demodekozy
EP3307268A4 (fr) Phenyl-oxazolidinones substituées pour la thérapie antimicrobienne
DK3408265T3 (da) Terapeutiske forbindelser
IL262851A (en) Combination prime: boost therapy
BR112017014839A2 (pt) novos microbicidas
EP3630331C0 (fr) Traitement de fluide
DK3302478T3 (da) Pac-1 kombinations behandling
MA46999A (fr) Oligonucléotides modifiés pour traiter la polykystose rénale
EP3554616C0 (fr) Applicateur antiseptique
DK3551166T3 (da) Topisk phenytoin til anvendelse i behandling af periferisk neuropatisk smerte